Paper20163115
Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
Ahmed AH and 1 other. J Med Chem, 2010. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. Papers, record 20163115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20163115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nootropic Agents | Major topic |
| Piracetam | Major topic |
| Pyrrolidinones | Major topic |
| Receptors, AMPA | Major topic |
| Allosteric Regulation | |
| Binding Sites | |
| Humans | |
| Mutagenesis, Insertional | |
| X-Ray Diffraction |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS049223 | NINDS NIH HHS | United States | R01NS049223 | PubMed and NIH | NIH RePORTER |
| DMR-0225180 | NIGMS NIH HHS | United States | PubMed | PubMed | |
| 1R21-NS067562 | NINDS NIH HHS | United States | R21NS067562 | PubMed and NIH | NIH RePORTER |
| R01-NS049223 | NINDS NIH HHS | United States | R01NS049223 | PubMed and NIH | NIH RePORTER |
| R21 NS067562 | NINDS NIH HHS | United States | R21NS067562 | PubMed and NIH | NIH RePORTER |
| P41 RR001646 | NCRR NIH HHS | United States | P41RR001646 | PubMed and NIH | NIH RePORTER |
| RR-01646 | NCRR NIH HHS | United States | P41RR001646 | PubMed and NIH | NIH RePORTER |
| R01 GM068935 | NIGMS NIH HHS | United States | R01GM068935 | PubMed and NIH | NIH RePORTER |
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17275103 | Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. | Trends Neurosci | 2007 | https://conductscience.org/library/papers/17275103 | PubMed |
| 2 | 9804426 | Structure of a glutamate-receptor ligand-binding core in complex with kainate. | Nature | 1998 | https://conductscience.org/library/papers/9804426 | PubMed |
| 3 | 16215279 | AMPA receptor subunit GluR2 gates injurious signals in ischemic stroke. | Mol Neurobiol | 2005 | https://conductscience.org/library/papers/16215279 | PubMed |
| 4 | 1372342 | Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures. | J Neurochem | 1992 | https://conductscience.org/library/papers/1372342 | PubMed |
| 5 | 1681589 | Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. | Science | 1991 | https://conductscience.org/library/papers/1681589 | PubMed |
| 6 | 15677325 | Structure of the kainate receptor subunit GluR6 agonist-binding domain complexed with domoic acid. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15677325 | PubMed |
| 7 | 16192394 | Mechanism of positive allosteric modulators acting on AMPA receptors. | J Neurosci | 2005 | https://conductscience.org/library/papers/16192394 | PubMed |
| 8 | 1975272 | Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. | J Physiol | 1990 | https://conductscience.org/library/papers/1975272 | PubMed |
| 9 | 18022568 | Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites. | Chem Biol | 2007 | https://conductscience.org/library/papers/18022568 | PubMed |
| 10 | 19003990 | Structure of the S1S2 glutamate binding domain of GLuR3. | Proteins | 2009 | https://conductscience.org/library/papers/19003990 | PubMed |
| 11 | 19102704 | Correlating AMPA receptor activation and cleft closure across subunits: crystal structures of the GluR4 ligand-binding domain in complex with full and partial agonists. | Biochemistry | 2008 | https://conductscience.org/library/papers/19102704 | PubMed |
| 12 | 17237803 | Regulatory mechanisms of AMPA receptors in synaptic plasticity. | Nat Rev Neurosci | 2007 | https://conductscience.org/library/papers/17237803 | PubMed |
| 13 | 17581823 | Partial agonism and antagonism of the ionotropic glutamate receptor iGLuR5: structures of the ligand-binding core in complex with domoic acid and 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17581823 | PubMed |
| 14 | 16442080 | A role for AMPA receptors in mood disorders. | Biochem Pharmacol | 2006 | https://conductscience.org/library/papers/16442080 | PubMed |
| 15 | 17256974 | GluR3 flip and flop: differences in channel opening kinetics. | Biochemistry | 2007 | https://conductscience.org/library/papers/17256974 | PubMed |
| 16 | 7973663 | A molecular determinant for submillisecond desensitization in glutamate receptors. | Science | 1994 | https://conductscience.org/library/papers/7973663 | PubMed |
| 17 | 11086992 | Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. | Neuron | 2000 | https://conductscience.org/library/papers/11086992 | PubMed |
| 18 | 10049997 | The glutamate receptor ion channels. | Pharmacol Rev | 1999 | https://conductscience.org/library/papers/10049997 | PubMed |
| 19 | 12215417 | Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core. | J Mol Biol | 2002 | https://conductscience.org/library/papers/12215417 | PubMed |
| 20 | 11518533 | Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state. | J Mol Biol | 2001 | https://conductscience.org/library/papers/11518533 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42438577 | Differential Improvement in Obsessive Rumination and Fantasy Intrusions Versus Attachment-Related Emotional Dysregulation During Oral Glutamatergic Augmentation in a 16-Year-Old Adolescent. | Cureus | 2026 | https://conductscience.org/library/papers/42438577 | PubMed |
| 42368238 | Optimized Oral Glutamatergic Augmentation in Refractory Home-Dominant Contamination Obsessive-Compulsive Disorder With Somatic, Affective, and Motivational Features: A Case Report of Incremental Functional Gains. | Cureus | 2026 | https://conductscience.org/library/papers/42368238 | PubMed |
| 42205993 | Case Report: Oral glutamatergic augmentation for trauma-related disorders with fluoxetine-/bupropion-potentiated dextromethorphan ± piracetam: a four-patient case series. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42205993 | PubMed |
| 42005166 | Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features. | Cureus | 2026 | https://conductscience.org/library/papers/42005166 | PubMed |
| 41739317 | Oxiracetam Improves Cognitive Disorder in AD by Modulating AMPAR Subunits GluA1/GluA2 Kinetics. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41739317 | PubMed |
| 41732374 | Glutamatergic Enhancement Using As-Needed Dextromethorphan and Piracetam in a Stimulant-Partially Responsive Adult With ADHD: A Single-Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/41732374 | PubMed |
| 38552113 | Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38552113 | PubMed |
| 36857176 | Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel. | Cell Rep | 2023 | https://conductscience.org/library/papers/36857176 | PubMed |
| 36552791 | Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain. | Cells | 2022 | https://conductscience.org/library/papers/36552791 | PubMed |
| 35743382 | Effects of Smart Drugs on Cholinergic System and Non-Neuronal Acetylcholine in the Mouse Hippocampus: Histopathological Approach. | J Clin Med | 2022 | https://conductscience.org/library/papers/35743382 | PubMed |
| 35366192 | Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals. | Drugs | 2022 | https://conductscience.org/library/papers/35366192 | PubMed |
| 35298129 | How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets? | ACS Chem Neurosci | 2022 | https://conductscience.org/library/papers/35298129 | PubMed |
| 34909030 | Neuroenhancement: State of the Art and Future Perspectives. | Clin Neuropsychiatry | 2021 | https://conductscience.org/library/papers/34909030 | PubMed |
| 34753794 | Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34753794 | PubMed |
| 32894462 | The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors. | Dokl Biochem Biophys | 2020 | https://conductscience.org/library/papers/32894462 | PubMed |
| 32468591 | Hodgkin-Huxley-Katz Prize Lecture: Genetic and pharmacological control of glutamate receptor channel through a highly conserved gating motif. | J Physiol | 2020 | https://conductscience.org/library/papers/32468591 | PubMed |
| 32013012 | Integrated Computational Approaches and Tools forAllosteric Drug Discovery. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32013012 | PubMed |
| 30864515 | Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline. | Curr Aging Sci | 2019 | https://conductscience.org/library/papers/30864515 | PubMed |
| 30581496 | Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel. | Behav Neurol | 2018 | https://conductscience.org/library/papers/30581496 | PubMed |
| 28674068 | Structural and Functional Analysis of the Escherichia coli Acid-Sensing Histidine Kinase EvgS. | J Bacteriol | 2017 | https://conductscience.org/library/papers/28674068 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CFLAR | 8837 | PubTator's text mining | https://conductscience.org/library/genes/8837 | NCBI Gene |
| GRIA2 | 2891 | PubTator's text mining | https://conductscience.org/library/genes/2891 | NCBI Gene |
| GRIA3 | 2892 | PubTator's text mining | https://conductscience.org/library/genes/2892 | NCBI Gene |
| GRIA4 | 2893 | PubTator's text mining | https://conductscience.org/library/genes/2893 | NCBI Gene |
| GRIK1 | 2897 | PubTator's text mining | https://conductscience.org/library/genes/2897 | NCBI Gene |
| GRIK2 | 2898 | PubTator's text mining | https://conductscience.org/library/genes/2898 | NCBI Gene |
| GRIN1 | 2902 | PubTator's text mining | https://conductscience.org/library/genes/2902 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20163115
GET https://conductscience.org/api/papers/v1/20163115/references?page=2